We are live on
!
Find out more
Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
AUM
$30.5B
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.25%
5 Year Est. Return
+106.98%
10 Year Est. Return
+342.87%
AUM
$65.7B
AUM Growth
+$262M
(+0.4%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
26.53%
Holding
362
New
36
Increased
82
Reduced
200
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$713M |
| 2 |
Cardinal Health
CAH
|
+$533M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$358M |
| 4 |
Fidelity National Financial
FNF
|
+$181M |
| 5 |
Elevance Health
ELV
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$518M |
| 2 |
Entergy
ETR
|
+$423M |
| 3 |
Honeywell
HON
|
+$287M |
| 4 |
CenterPoint Energy
CNP
|
+$264M |
| 5 |
Johnson & Johnson
JNJ
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.02% |
| 2 | Healthcare | 19.84% |
| 3 | Industrials | 14.73% |
| 4 | Energy | 11.33% |
| 5 | Technology | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHS
251
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.21M | ﹤0.01% |
52,386
-261
| -0.5% | -$9.79K |
|
|
ZVO
252
DELISTED
Zovio Inc. Common Stock
ZVO
| $2.12M | ﹤0.01% |
292,613
+22,997
| +9% | +$197K |
|
|
SMRT
253
DELISTED
Stein Mart Inc
SMRT
| $2.11M | ﹤0.01% |
273,434
+75,645
| +38% | +$528K |
|
254
CNO Financial Group
CNO
$5.16B
| $2.07M | ﹤0.01% |
118,463
-904
| -0.8% | -$17K |
|
255
Consolidated Edison
ED
$39.3B
| $1.98M | ﹤0.01% |
24,582
| – | – |
|
256
TriMas Corp
TRS
$1.43B
| $1.96M | ﹤0.01% |
108,743
-399
| -0.4% | -$6.92K |
|
|
FRP
257
DELISTED
Fairpoint Communications, Inc.
FRP
| $1.92M | ﹤0.01% |
130,644
+9,846
| +8% | +$139K |
|
|
LORL
258
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.9M | ﹤0.01% |
+53,880
| New | +$1.96M |
|
|
NCI
259
DELISTED
Navigant Consulting, Inc.
NCI
| $1.88M | ﹤0.01% |
116,242
-364
| -0.3% | -$5.75K |
|
|
ASNA
260
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.65M | ﹤0.01% |
11,812
+47
| +0.4% | +$7.62K |
|
261
Dominion Energy
D
$58.9B
| $1.6M | ﹤0.01% |
20,578
| – | – |
|
|
CCC
262
DELISTED
Calgon Carbon Corp
CCC
| $1.57M | ﹤0.01% |
+119,081
| New | +$1.76M |
|
263
Columbus McKinnon
CMCO
$566M
| $1.46M | ﹤0.01% |
103,085
-21,214
| -17% | -$328K |
|
264
Comtech Telecommunications
CMTL
$51.8M
| $1.45M | ﹤0.01% |
113,139
+39,702
| +54% | +$833K |
|
|
BBRG
265
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $1.42M | ﹤0.01% |
173,376
-48,912
| -22% | -$369K |
|
|
APOL
266
DELISTED
Apollo Education Group Inc Class A
APOL
| $1.42M | ﹤0.01% |
155,488
-421
| -0.3% | -$3.63K |
|
|
MTSC
267
DELISTED
MTS Systems Corp
MTSC
| $1.41M | ﹤0.01% |
+32,233
| New | +$1.62M |
|
268
Penske Automotive Group
PAG
$14.2B
| $1.39M | ﹤0.01% |
44,136
-11
| -0% | -$402 |
|
269
International Bancshares
IBOC
$4.53B
| $1.35M | ﹤0.01% |
51,719
-157
| -0.3% | -$4.12K |
|
|
SHOE
270
Shoe Station Group
SHOE
$436M
| $1.33M | ﹤0.01% |
106,606
-1,274
| -1% | -$15.8K |
|
271
Abercrombie & Fitch
ANF
$5.26B
| $1.25M | ﹤0.01% |
+69,956
| New | +$1.67M |
|
272
Duke Energy
DUK
$95.1B
| $1.25M | ﹤0.01% |
14,515
| – | – |
|
273
Par Pacific Holdings
PARR
$3.61B
| $1.19M | ﹤0.01% |
+77,224
| New | +$1.32M |
|
|
MAGN
274
Magnera Corp
MAGN
$454M
| $1.15M | ﹤0.01% |
+4,528
| New | +$1.22M |
|
|
FRED
275
DELISTED
Fred's Inc
FRED
| $1.12M | ﹤0.01% |
+69,272
| New | +$1.02M |
|
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 Portfolio in Review
As of Q2 2016, Barrow, Hanley, Mewhinney & Strauss held 362 positions worth $65.7B, up 0.4% from $65.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 filing shows 36 new, 82 increased, 200 reduced and 39 closed positions. Its largest new stake was Fidelity National Financial: 7,688,148 shares worth $200M. The largest sale was Medtronic, an estimated $518M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
- Barrow, Hanley, Mewhinney & Strauss's largest Q2 2016 buy was Fidelity National Financial: 7,688,148 shares worth $200M.
- Barrow, Hanley, Mewhinney & Strauss added most to Teva Pharmaceuticals in Q2 2016, an estimated $713M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q2 2016 reduction was Medtronic, cutting an estimated $518M.
- Barrow, Hanley, Mewhinney & Strauss fully exited People's United Financial Inc in Q2 2016, selling an estimated $180M.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 27% of its $65.7B portfolio in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss opened 36 new positions and closed 39 in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value rose 0.4% quarter-over-quarter to $65.7B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2016, filed 8 Aug 2016.